Biocytogen Boston Corp

Waltham, MA

UEI
SN23DNZQQTF9
CAGE
9FYY0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
300 3rd Ave FL 6, Waltham, MA 02451, USA
Website
biocytogen.com
Founded
2009
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $44,320
FY2024 $38,099
FY2023 $200,200

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Biocytogen Boston Corp is a for-profit, tax-exempt corporate entity specializing in genetically engineered animal models and scientific research services. Located in Waltham, Massachusetts, the company focuses on developing advanced transgenic and knockout animal models for biomedical research purposes. The organization is registered in SAM.gov and has been actively receiving federal contract awards, primarily from various National Institutes of Health (NIH) agencies and the Department of Veterans Affairs.

The company has consistently secured federal contract awards for highly specialized scientific services, predominantly involving the development of custom transgenic and knockout animal models. Specifically, Biocytogen Boston Corp has provided services such as creating knock-in mouse models, CRISPR knockout rat models, and specialized rat lines for research purposes. The federal contract awards have been firm fixed-price purchase orders ranging from $13,100 to $156,200, awarded by agencies including the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Drug Abuse (NIDA), National Cancer Institute (NCI), and Veterans Integrated Service Network 15 (VA - VHA VISN 15). These contracts support critical research initiatives in areas such as HIV transmission, alcoholism, drug abuse, and cancer research. None of the contracts included specific set-aside designations, and Biocytogen Boston Corp has operated as a prime contractor in these federal awards, delivering highly specialized scientific research services and genetically modified animal models to support advanced medical research.

Quick answers

Is Biocytogen Boston Corp registered in SAM.gov?

Yes. Biocytogen Boston Corp's SAM.gov registration is active through July 28, 2027.

What is Biocytogen Boston Corp's CAGE code?

Biocytogen Boston Corp's CAGE code is 9FYY0, and its Unique Entity ID (UEI) is SN23DNZQQTF9.

How much has Biocytogen Boston Corp received in federal contracts?

Federal contracts obligated $44,320 to Biocytogen Boston Corp in fiscal year 2025 and $282,619 in fiscal years 2023 through 2027.

What is Biocytogen Boston Corp's most recent federal award?

Biocytogen Boston Corp's most recent federal contract award is This firm fixed price purchase order is awarded for specialized knock-in mouse models to biocytogen boston corp:1375719… (75N94025P00385), from National Institute of Child Health and Human Development (NIH), on July 15, 2025.

On GovTribe

See Biocytogen Boston Corp's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe